Search Within

Sergio Andres Giralt

  1. "Master of Science in Clinical and Translational Cancer Research "
Formats
  1. Meeting Abstract (244)
  2. Journal Article (120)
  3. Research Letter (10)
  4. Review (7)
Groups
  1. Bone Marrow Transplant (381)
  2. CTCR Scholars (381)
  3. Center for Hematologic Malignancies (381)
  4. Department of Medicine (381)
  5. Hematologic Malignancies, Division of (381)
  6. MSK Grad Students (381)

More Groups

People
  1. Miguel-Angel Perales (288)
  2. Sean Devlin (220)
  3. Parastoo Dahi (207)
  4. Doris Ponce (193)
  5. Ann Jakubowski (169)
  6. Esperanza Papadopoulos (165)

More People

Years
  1. 2025 (5)
  2. 2024 (9)
  3. 2023 (32)
  4. 2022 (32)
  5. 2021 (31)
  6. 2020 (45)

More Years

Publications
  1. Biology of Blood and Marrow Transplantation (131)
  2. Blood (111)
  3. Bone Marrow Transplantation (38)
  4. Transplantation and Cellular Therapy (23)
  5. Blood Advances (18)
  6. Leukemia and Lymphoma (8)

More Publications

Publishers
  1. Elsevier Inc. (159)
  2. American Society of Hematology (129)
  3. Nature Publishing Group (41)
  4. Taylor & Francis Group (10)
  5. American Society of Clinical Oncology (5)
  6. Oxford University Press (5)

More Publishers

Results (381)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Ex vivo CD34(+)–selected T cell–depleted peripheral blood stem cell grafts for allogeneic hematopoietic stem cell transplantation in acute leukemia and myelodysplastic syndrome is associated with low incidence of acute and chronic graft-versus-host disease and high treatment response
    Journal Article

    Barba, P.; Hilden, P.; Devlin, S. M.; Maloy, M.; Dierov, D.; Nieves, J.; Garrett, M. D.; Sogani, J.; Cho, C.; Barker, J. N.; more...
    Biology of Blood and Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • Hematopoietic cell transplantation comorbidity index predicts outcomes in patients with acute myeloid leukemia and myelodysplastic syndromes receiving CD34(+) selected grafts for allogeneic hematopoietic cell transplantation
    Journal Article

    Barba, P.; Ratan, R.; Cho, C.; Ceberio, I.; Hilden, P.; Devlin, S. M.; Maloy, M. A.; Barker, J. N.; Castro-Malaspina, H.; Jakubowski, A. A.; more...
    Biology of Blood and Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • A comprehensive assessment of toxicities in patients with central nervous system lymphoma undergoing autologous stem cell transplantation using thiotepa, busulfan, and cyclophosphamide conditioning
    Journal Article

    Scordo, M.; Bhatt, V.; Hsu, M.; Omuro, A. M.; Matasar, M. J.; DeAngelis, L. M.; Dahi, P. B.; Moskowitz, C. H.; Giralt, S. A.; Sauter, C. S.
    Biology of Blood and Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • Selection of unrelated allogeneic hematopoietic cell donors based on KIR3DL1 allotypes is feasible and results in improved disease-free survival in transplant recipients with MDS and AML
    Meeting Abstract

    Shaffer, B. C.; Heller, G.; Le Luduec, J. B.; Vahradian, J.; Perales, M.; Giralt, S. A.; Tamari, R.; Gyurkocza, B.; Jakubowski, A. A.; Papadopoulos, E. B.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Comparable survival and incidence of toxicity for older adult patients after CD34+ selected allogeneic hematopoietic stem cell transplantation
    Meeting Abstract

    Shah, G. L.; Scordo, M.; Kosuri, S.; Herrera, D. A.; Maloy, M. A.; Nieves, J.; Devlin, S.; Borrill, T.; Avecilla, S. T.; Meagher, R. C.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Third party CMV-specific cytotoxic T cells for treatment of antiviral resistant CMV infection after hematopoietic stem cell transplant
    Meeting Abstract

    Prockop, S.; Doubrovina, E.; Hasan, A. N.; Dahi, P. B.; Giralt, S.; Koehne, G.; Kernan, N. A.; Papadopoulos, E. B.; Lehrman, R.; Rodriguez-Sanchez, I.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Despite increasing size of unrelated donor (URD) registries and the global cord blood (CB) inventory racial disparities in access to URD and CB grafts persist: A prospective 10 year analysis of 1,112 patients
    Meeting Abstract

    Boughan, K.; Dahi, P. B.; Devlin, S.; Byam, C.; Yoo, Y.; Mazis, C.; Davis, E.; Nhaissi, M.; Paulson, J.; Wells, D.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • A comprehensive analysis of late toxicities and associated risk factors in long-term survivors of myeloablative conditioned allogeneic hematopoietic cell transplantation using ex-vivo CD34+ selection-based graft-versus-host disease prophylaxis
    Meeting Abstract

    Scordo, M.; Shah, G. L.; Kosuri, S.; Herrera, D. A.; Devlin, S.; Maloy, M. A.; Nieves, J.; Borrill, T.; Avecilla, S. T.; Meagher, R. C.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Impact of genomic alterations on outcomes in myelofibrosis patients undergoing allogeneic hematopoietic stem cell transplantation
    Meeting Abstract

    Rampal, R. K.; Tamari, R.; Zhang, N.; McNamara, C. J.; Rapaport, F.; Litvin, R.; Maloy, M. A.; Castro-Malaspina, H.; Giralt, S.; Weinberg, R. S.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • A novel intermediate intensity conditioning regimen achieves high rates of long-term outpatient progression-free survival offsetting the disadvantage of early post-transplant complications in adult cord blood (CB) transplant recipients
    Meeting Abstract

    Politikos, I.; Devlin, S.; Yoo, Y.; Mazis, C.; Maloy, M. A.; Scaradavou, A.; Dahi, P. B.; Perales, M.; Giralt, S.; Ponce, D. M.; more...
    Blood (2016)

    Fulltext@MSK | Save